BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 341.80
+9.20 (2.77%)
At close: Apr 14, 2026
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 30.32 billion as of April 14, 2026. Its market cap has increased by 86.16% in one year.
Market Cap
30.32B
Enterprise Value
28.18B
Revenue
2.00B
Ranking
n/a
PE Ratio
29.67
Stock Price
341.80
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 2.55B to 30.32B, an increase of 1,087.45%. That is a compound annual growth rate of 33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 30.32B | 10.07% |
| Dec 30, 2025 | 27.55B | 56.23% |
| Dec 30, 2024 | 17.63B | -25.44% |
| Dec 29, 2023 | 23.65B | -1.34% |
| Dec 30, 2022 | 23.97B | 128.37% |
| Dec 30, 2021 | 10.50B | 24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camurus AB | 31.88B |
| Hansa Biopharma AB | 3.05B |
| Vicore Pharma Holding AB | 2.81B |
| Egetis Therapeutics AB | 2.32B |
| Flerie AB | 2.29B |
| Saniona AB | 2.14B |
| BioInvent International AB | 1.51B |
| Genovis AB (publ.) | 1.31B |